<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04306536</url>
  </required_header>
  <id_info>
    <org_study_id>parere 72_2020bis</org_study_id>
    <nct_id>NCT04306536</nct_id>
  </id_info>
  <brief_title>Nutritional Support in Femur Fracture Rehabilitation</brief_title>
  <official_title>Muscle-targeted Nutritional Support in Post-surgical Rehabilitation for Femur Fracture</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Barichella Michela</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ASST Gaetano Pini-CTO</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized, observer-blinded trial tested the hypothesis that nutritional
      supplementation with muscle-target nutritional supplementation would increase the efficacy of
      a physical rehabilitation program in old adults with femur fracture treated with surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Muscle-target nutritional supplementation has been domonstrated to enhance the recovery of
      muscle mass and increase the efficacy of a rehabilitation program in patients suffering from
      sarcopenia. Femure fracture is responsible for increased immobilization resulting in loss of
      muscle mass which may be further emphasized by surgical stress. This randomized,
      observer-blinded trial tested the hypothesis that nutritional supplementation with
      muscle-target nutritional supplementation would increase the efficacy of a physical
      rehabilitation program in old adults with femur fracture treated with surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 19, 2020</start_date>
  <completion_date type="Anticipated">December 20, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 20, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Physical performance - gait speed</measure>
    <time_frame>4 weeks</time_frame>
    <description>Gait speed at the 10-meter walking test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physical performance - Timed Up and Go test</measure>
    <time_frame>4 weeks</time_frame>
    <description>Change in timed up and go test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional status - Barthel</measure>
    <time_frame>4 weeks</time_frame>
    <description>Change in Barthel index score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional status - handgrip strength</measure>
    <time_frame>4 weeks</time_frame>
    <description>Change in handgrip strength</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition - phase angle</measure>
    <time_frame>4 weeks</time_frame>
    <description>Change in phase angle</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition - muscle mass</measure>
    <time_frame>4 weeks</time_frame>
    <description>Change in muscle mass</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition - fat-free mass</measure>
    <time_frame>4 weeks</time_frame>
    <description>Change in fat-free mass</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition - fat-free mass index</measure>
    <time_frame>4 weeks</time_frame>
    <description>Change in fat-free mass index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body weight</measure>
    <time_frame>4 weeks</time_frame>
    <description>Change in body weight</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Calf circumference</measure>
    <time_frame>4 weeks</time_frame>
    <description>Change in calf circumference</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modality of discharge</measure>
    <time_frame>4 weeks</time_frame>
    <description>Difference in the proportion of patients discharged at home</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Femur Fracture</condition>
  <arm_group>
    <arm_group_label>Fortifit®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Best local diet + two servings (40 grams each) of powder (Fortifit®; Nutricia) which has to be dissolved in 125 ml of water. Per serving, 20 g whey protein, 3 g total leucine, 9 g carbohydrates, 3 g fat, 800 IU vitamin D, and a mixture of vitamins, minerals, and fibers.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Best local diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fortifit®</intervention_name>
    <description>Best local diet + two servings (40 grams each) of powder (Fortifit®; Nutricia) which has to be dissolved in 125 ml of water. Per serving, 20 g whey protein, 3 g total leucine, 9 g carbohydrates, 3 g fat, 800 IU vitamin D, and a mixture of vitamins, minerals, and fibers.</description>
    <arm_group_label>Fortifit®</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 60 years or older

          -  admission for physical rehabilitation after surgery for femur fracture

          -  informed consent

        Exclusion Criteria:

          -  Any malignant disease during the last five years

          -  Known kidney failure (previous glomerular filtration rate &lt;30 ml/min);

          -  Known liver failure (Child B or C)

          -  Psychiatric disease

          -  Severe cognitive impairment (Mini Mental State Examination &lt;18)

          -  Endocrine disorders associated with disorders of calcium metabolism (excluding
             osteoporosis)

          -  Indications related to the study product:

               1. More than 10 µg (400 IU) of daily Vitamin D intake from medical sources

               2. More than 500 mg of daily calcium intake from medical sources.

               3. Adherence to a high-energy or high-protein diet (up to three months before
                  starting the study)

               4. Hypersensitivity to any component of the investigational nutritional supplement
                  (including cow milk protein allergy to milk and lactose intolerance)

          -  Indication to or ongoing artificial nutrition support

          -  Inclusion in other nutrition intervention trials

          -  Investigator's uncertainty about the willingness or ability of the subject to comply
             with the protocol requirements

          -  Refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lorenzo Panella, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>ASST Gaetano Pini-CTO</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michela Barichella, MD</last_name>
    <phone>02947743222</phone>
    <phone_ext>0039</phone_ext>
    <email>Michela.Barichella@asst-pini-cto.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Asst Gaetano Pini</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michela Barichella</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>March 10, 2020</study_first_submitted>
  <study_first_submitted_qc>March 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 13, 2020</study_first_posted>
  <last_update_submitted>July 22, 2020</last_update_submitted>
  <last_update_submitted_qc>July 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>ASST Gaetano Pini-CTO</investigator_affiliation>
    <investigator_full_name>Barichella Michela</investigator_full_name>
    <investigator_title>Study coordinator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Femoral Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

